Screener
Corcept Therapeutics CORT Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $256.15M+31.7% | $164.9M+4.9% | $202.13M+11.1% | $207.64M+13.7% | $194.43M+18.7% | ||
| $4.06M+18.3% | $2.88M+20.0% | $2.55M-13.9% | $4.6M+60.3% | $3.43M+36.0% | ||
| $53.89M-10.9% | $66.27M+9.1% | $64.86M-7.7% | $68.85M+16.0% | $60.47M+2.9% | ||
| $156.9M+51.1% | $145.36M+60.3% | $130.24M+56.2% | $123.98M+68.1% | $103.85M+55.2% | ||
| $214.85M+28.1% | $214.5M+39.5% | $197.64M+26.2% | $197.42M+45.2% | $167.76M+30.9% | ||
| $41.3M+54.8% | -$49.6M-1,552% | $4.49M-82.2% | $10.22M-78.1% | $26.68M-25.1% | ||
| 16.1%+2.4pp | -30.1%-32.3pp | 2.2%-11.7pp | 4.9%-20.6pp | 13.7%-8.0pp | ||
| $4.63M-7.7% | $4.89M-21.2% | $5.42M-19.0% | $5.02M-20.8% | $5.02M-16.4% | ||
| $45.93M+44.9% | -$44.72M-565% | $9.91M-69.0% | $15.24M-71.2% | $31.69M-23.8% | ||
| $2.94M+185% | -$12.95M-18.5% | -$14.38M-1,284% | -$4.43M-177% | -$3.46M-157% | ||
| $42.99M+22.3% | -$31.76M-255% | $24.29M-21.0% | $19.67M-58.3% | $35.15M-1.0% | ||
| 16.8%-1.3pp | -19.3%-32.3pp | 12%-4.9pp | 9.5%-16.4pp | 18.1%-3.6pp | ||
| $0.36+24.1% | -$0.30-276% | $0.20-20.0% | $0.16-61.0% | $0.29-9.4% | ||
| $42.16M+56.4% | -$49M-1,424% | $4.78M-81.3% | $10.51M-77.6% | $26.96M-24.5% | ||
| 16.5%+2.6pp | -29.7%-32.1pp | 2.4%-11.7pp | 5.1%-20.6pp | 13.9%-7.9pp | ||
| $41.3M+54.8% | -$49.6M-1,552% | $4.49M-82.2% | $10.22M-78.1% | $26.68M-25.1% |
FAQ
- What is Corcept Therapeutics's revenue?
- Corcept Therapeutics (CORT) generated $830.8M in revenue over the trailing twelve months, up 16.0% year over year.
- Is Corcept Therapeutics profitable?
- Corcept Therapeutics reported $55.2M in net income over the trailing twelve months, a 6.6% net margin.
- What are Corcept Therapeutics's profit margins?
- Gross margin is 98.3% and operating margin is 0.8%, with a 6.6% net margin.
- What is Corcept Therapeutics's earnings per share?
- Corcept Therapeutics's diluted EPS over the trailing twelve months is $0.42.
- Where does Corcept Therapeutics's income statement data come from?
- Every line is extracted from Corcept Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
